Try the new FT.com

    Search for Merck & Co Inc and
    1. February 15, 2017

      Merck’s drug failure deals further blow to Alzheimer’s theory

      Merck’s most senior scientist said it was “too early” to reject the main theory of what causes Alzheimer’s disease...

    2. Fast FT

      February 14, 2017

      Merck ends a late-stage study of Alzheimer's drug

      Merck announced that it was ending a late-stage study of its Alzheimer’s drug after a committee monitoring the trial...

    Special Reports

    1. Inventions and Patents

      Patenting has never been more popular. Applications have reached record levels at the ...
    2. Combating Cancer

      We consider the latest in cell therapy and efforts to arm the immune system in the fig...
    Search more Special Reports on this topic.

    1. February 9, 2017

      Big pharma faces costly setback in cancer fight

      When Cary Parton pulled a back muscle playing golf four years ago, he hardly gave it a second thought. But after...

    2. February 2, 2017

      Merck hails rise in patient tests for immunotherapy drug Keytruda

      Merck & Co has seen a big jump in the number of lung cancer patients being tested to see if they would benefit from its...

    3. January 31, 2017

      Pharma stocks rally on Trump pledge to speed drug approvals

      Donald Trump has said his administration will significantly cut the length of time it takes to win regulatory approval...

    4. January 20, 2017

      Bristol-Myers shares slide on immunotherapy setback

      Bristol-Myers Squibb dashed hopes that it would quickly regain its lead in the fiercely contested race to develop a new...

    5. Fast FT

      January 11, 2017

      Merck shares get a shot in the arm as cancer drug gets priority review

      Merck & Co shares rose 5.4 per cent on Wednesday, after it got a welcome boost from US regulators in its battle to lead...

    6. Fast FT

      December 15, 2016

      Jury orders Gilead to pay Merck $2.54bn in damages in patent trial

      A US jury on Thursday ordered Gilead Sciences to pay a subsidiary of Merck & Co $2.54bn in damages in a...

    7. Fast FT

      December 7, 2016

      Trump vows to bring down drug prices, biotech stocks tumble

      Investors who have been piling into biotechnology stocks were dealt a rude reality check on Wednesday. Having rallied...

    8. October 9, 2016

      Bristol-Myers lung cancer drug fails to meet immunotherapy hopes

      A new drug from Bristol-Myers Squibb that turns the body into a weapon against cancer failed to beat chemotherapy in a...

    9. August 30, 2016

      Merck plays long game in precision medicine battle

      Merck and Bristol-Myers Squibb have spent most of the past two years in a two-horse race to develop and sell...

    10. August 8, 2016

      Allergan setback prompts healthcare slide

      Healthcare stocks in the US slid on Monday in a lacklustre trading session as investors digested disappointing results...

    11. August 5, 2016

      Bristol-Myers’ value plunges as cancer drug fails

      A new blockbuster cancer drug Bristol-Myers Squibb hoped would become a replacement for chemotherapy in most lung...

    12. August 1, 2016

      Nanoco lands key deal as Merck signs on quantum dotted line

      Nanoco has made a significant commercial breakthrough with its quantum-dot technology for displays, signing up Merck as...

    13. June 17, 2016

      Wall Street endures second straight weekly loss

      US stocks suffered a second straight weekly decline on Friday, weighed down by the technology and healthcare sectors....

    14. June 2, 2016

      Brakes off in effort to confront melanoma

      Thanks to its terrible prognosis, melanoma was once known as the cancer that gave others a bad name. Now a type of...

    15. June 2, 2016

      President raises patient and business hope for cancer treatment

      When Jimmy Carter was diagnosed last year with melanoma that had spread to his brain, many people feared the worst for...

    16. June 1, 2016

      Cancer doctors face next drug challenge

      More than 30,000 doctors and scientists will gather in Chicago this weekend for the biggest annual meeting of cancer...

    17. May 19, 2016

      Pull together to prevent a superbug apocalypse

      Jim O’Neill, UK Treasury minister and former Goldman Sachs economist, has focused the world’s attention on...

    18. Fast FT

      May 19, 2016

      Merck KGaA boosted by acquisition in Q1

      Merck KGaA saw a substantial rise in both sales and profits in the first quarter, the first period in which a recent...

    19. May 9, 2016

      Pfizer to trial triple-combination cancer treatment

      Pfizer plans to test a combination of three novel cancer drugs in humans next year, as the US drugmaker seeks to make...

    20. Fast FT

      May 5, 2016

      Merck raises underlying earnings guidance

      US drugmaker Merck has raised its full year guidance for underlying earnings per share despite sales edging down 1 per...

    21. April 26, 2016

      Tony Coles – on a mission to tackle Alzheimer’s

      After brokering the $10bn sale of the biotech company he led, Tony Coles planned to follow the well-trodden path of...

    22. February 1, 2016

      Finance sector pay shifts from bonuses to salaries, says Mercer survey

      The world’s banks, insurers and investment managers continued to cut staff bonuses last year in favour of increasing...

    23. January 31, 2016

      Gilead risks becoming victim of its own success

      During the past two years, Gilead, a California-based drugmaker, has emerged as the undisputed leader of the four large...

    24. January 29, 2016

      Merck launches hepatitis C drug price war

      Merck has launched a price war in the treatment of hepatitis C by setting the list price of its new drug at a 40 per...

    25. January 25, 2016

      Brexit would be a ‘mistake’, say global pharma leaders

      A British exit from the EU would isolate the country’s scientists and reduce its influence in medicine, global...

    26. January 23, 2016

      Why the Disrupted are privately griping about tech upstarts at Davos

      Given the theme of this year’s World Economic Forum was the Fourth Industrial Revolution, it was natural that Silicon...

    27. January 15, 2016

      Merck of Germany wins UK support in battle with US namesake

      Merck of Germany has won the backing of a UK court in its battle with Merck of the US over the family name shared by...

    28. December 15, 2015

      Sanofi/Boehringer: swap shop

      Swapping assets was a form of human trade since long before bankers and their fees arrived on the scene. In...

    29. December 14, 2015

      AstraZeneca: in search of a blockbuster

      Jimmy Carter can tell you why AstraZeneca is contemplating paying $5bn for an unquoted Dutch biotech company with a...

    30. FT Alphaville

      December 4, 2015

      Relypsa: the next US biotech M&A target?

      StreetInsider.com reports: Merck & Co (NYSE: MRK) plans to make a non-binding offer to acquire Relypsa, (Nasdaq: RLYP),...

    31. December 1, 2015

      Eli Lilly and Merck bolstered by upgrades

      Pharmaceutical stocks received a shot in the arm after analysts at Barclays upgraded Eli Lilly and Merck citing...

    32. November 26, 2015

      Unhealthy drugs: Pharma struggles with its reputation

      An industry dedicated to saving and extending lives might be expected to find empathy easy. Instead, some of the...

    33. November 22, 2015

      Pfizer-Allergan tie-up would mark M&A high point

      Pfizer’s imminent $150bn takeover of Allergan to create the world’s biggest drugmaker will mark a fresh pinnacle in an...

    34. November 13, 2015

      Animal health: double or quits

      Sea lice. Fowl pox. Swine fever. Foot-and-mouth. Animal diseases often take prosaic names. This does not make them...

    35. October 12, 2015

      Eli Lilly’s heart-drug setback reverberates through pharma sector

      Shares of several of the US’s largest drugmakers were roiled on Monday after Eli Lilly surprisingly halted development...

    36. October 12, 2015

      Eli Lilly shares sink as it scraps heart drug

      Eli Lilly has pulled the plug on a potential blockbuster medicine intended to ward off heart attacks and strokes,...

    37. October 9, 2015

      Scots nurse ‘serious’ with Ebola after-effects as epidemic fades

      A Scottish nurse suffering the after-effects of Ebola was readmitted to an isolation unit on Friday — highlighting...

    38. September 7, 2015

      Groundbreaking cancer drug given NHS approval

      A groundbreaking new cancer drug that harnesses the immune system to kill tumours has been recommended for use by the...

    Search for Merck & Co Inc and